Contribution of telacebec to novel drug regimens in a murine tuberculosis model
O. D. Komm, S. Tyagi, A. Garcia, D. V. Almeida, Y. S. Chang, S.-Y. Li, J. R. Castillo, P. J. Converse, T. Black, N. Fotouhi, E. L. Nuermberger
This study evaluates telacebec's contribution to combination therapies against two M. tuberculosis strains in a murine model, finding synergistic effects against HN878 and antagonistic effects against H37Rv.
bioRxiv · Jun 27, 2024Microbiology